OrsoBio
CA - Palo AltoBiotechnology
Focus: OrsoBio is a clinical-stage biotechnology company focused on mitochondrial protonophores with applications in oncology and metabolic diseases. The company is headquartered in Palo Alto, California and operates as a pre-revenue biotech with an early-stage pipeline.
Profile data last refreshed Yesterday · AI intelligence enriched 1w ago
Open Jobs
0
About OrsoBio
AI assessmentNot HiringNo open roles listed right now. Follow OrsoBio to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
5 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
TLC-2716
Healthy SubjectsClinical Trials (1)
NCT05483998A Study to Evaluate Single and Multiple Doses of TLC-2716 in Healthy Participants
Phase 1Help build intelligence for OrsoBio
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.